Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Ebitda
Keuangan
Harga Saham
USD
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 15.86B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Ebitda
Perubahan
Tanggal
Agilent
USD 577M
77M
2026-06
Align Technology
USD 229.14M
31.74M
2026-03
Bio Techne
USD 115.94M
763K
2026-06
Bio-Rad Laboratories
USD 595.3M
1.23B
2026-06
Bruker
USD 143.2M
33.2M
2026-06
Celltrion
KRW 19.64B
1.85B
2026-03
Charles River Laboratories
USD 272.95M
43.14M
2026-06
Cspc Pharmaceutical
CNY 2.19B
21.88M
2024-12
Danaher
USD 1.84B
81M
2026-06
Dentsply International
USD 190M
61M
2026-06
Deva Holding AS
TRY 882.9M
201.7M
2023-09
Dianthus Therapeutics
USD -46.46M
6.27M
2026-03
Divis Laboratories Ltd
INR 12.62B
3.28B
2026-06
Edwards Lifesciences
USD 555.6M
485.5M
2026-03
Illumina
USD 330M
80M
2026-06
Intuitive Surgical
USD 1.06B
29.9M
2026-03
IQVIA Holdings
USD 994M
62M
2026-06
Kangmei Pharma
CNY -12.72M
30.02M
2026-03
Knight Therapeutics
CAD 24.45M
3.46M
2025-12
Laboratorios Farma
EUR 34.94M
102.95M
2025-06
Laboratory Of America
USD 767.7M
162.1M
2026-06
Malin Corporation
EUR -1.1M
200K
2024-12
Medical Developments International
AUD 1.78M
3.78M
2024-12
Mesa Laboratories
USD 9.58M
1.47M
2024-09
Mettler Toledo International
USD 322.64M
43.66M
2026-06
Myriad Genetics
USD 14.3M
4M
2025-12
Neuren Pharmaceuticals
AUD 11.14M
165.56M
2025-12
OraSure Technologies
USD -17.7M
4.06M
2025-12
Organigram Holdings
CAD -4.76M
10.02M
2026-03
Pacific Biosciences Of California
USD -35.4M
5.78M
2025-09
Pharma Mar
EUR 700K
2.01M
2026-06
Qiagen NV
USD 207.66M
59.56M
2026-06
Quest Diagnostics
USD 648M
91M
2026-06
Quidel
USD 129.3M
20.6M
2026-06
Repligen
USD 43.77M
3.76M
2026-06
Revvity
USD 228.18M
44.73M
2026-06
Sartorius
EUR 280.5M
13.2M
2026-06
Sino Biopharmaceutical
CNY 2.59B
1.57B
2024-12
Thermo Fisher Scientific
USD 3.55B
845M
2026-06
Tilray
USD 8.36M
1.82M
2025-09
Waters
USD 712M
545M
2026-06
Zealand Pharma A/S
-379M
348.47M
2026-03
Zhangzhou Pientzehuang Pharmaceutical
CNY 882.7M
351.1M
2026-03
×